Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk-benefit equation
- PMID: 31356721
- DOI: 10.1111/codi.14794
Selective central vascular ligation (D3 lymphadenectomy) in patients undergoing minimally invasive complete mesocolic excision for colon cancer: optimizing the risk-benefit equation
Abstract
Aim: Complete mesocolic excision (CME) with central vascular ligation (CVL) has been advocated for right colon adenocarcinoma (RC), but the radicality of vascular dissection remains controversial. Our aim is to report outcomes of selective CVL (D3 lymphadenectomy) during minimally invasive CME for RC.
Method: A prospective database identified patients who were treated for RC between 2009 and 2016. Minimally invasive CME was standard. The radicality of lymphadenectomy was defined as high ligation (HL) versus CVL based on operative reports and videos. Two blinded radiologists independently evaluated the pre- and postoperative CT scans for radiographically abnormal nodes.
Results: Of 197 patients who underwent CME, HL was performed in 56 (28%) and CVL in 141 (72%). There were no baseline differences in age, sex, body mass index, American Society of Anesthesiologists score or pathological staging, and there were no major intra-operative complications in either group (including no major vascular injuries). The median total number of nodes retrieved was 27 and 31 (P = 0.011) in HL and CVL groups, resepctively, with pathologically positive nodes identified in 33.9% and 39.8% (P = 0.704), respectively. Preoperative imaging identified abnormal cN3 nodes in 1.5% of patients; all of whom underwent CVL. No abnormal cN2 or cN3 nodes remained on postoperative imaging. The 60-day mortality was 0.5%, and major morbidity was 4%. One patient (0.5%) had an anastomotic recurrence after a median follow-up of 22 months.
Conclusion: With imperfect preoperative clinical nodal staging, and in the absence of randomized data, the low morbidity and oncological outcomes observed support the approach of CME with HL as a minimum standard, with CVL (D3 lymphadenectomy) in selected cases.
Keywords: CME; D3; central vascular ligation; complete mesocolic excision; lymph nodes; lymphadenectomy.
Colorectal Disease © 2019 The Association of Coloproctology of Great Britain and Ireland.
Similar articles
-
Laparoscopic middle colic artery-preserved right hemicolectomy with true D3 lymph node dissection for right-sided colon cancer: modified complete mesocolic excision.Surg Endosc. 2021 May;35(5):2386-2388. doi: 10.1007/s00464-020-08254-4. Epub 2021 Jan 6. Surg Endosc. 2021. PMID: 33409595
-
Initial retrocolic endoscopic tunnel approach (IRETA) for complete mesocolic excision (CME) with central vascular ligation (CVL) for right colonic cancers: technique and pathological radicality.Int J Colorectal Dis. 2016 Feb;31(2):227-33. doi: 10.1007/s00384-015-2415-3. Epub 2015 Oct 22. Int J Colorectal Dis. 2016. PMID: 26493187
-
Complete mesocolic excision for right colon cancer: Is D3 lymphadenectomy necessary?Colorectal Dis. 2024 Jan;26(1):63-72. doi: 10.1111/codi.16815. Epub 2023 Nov 28. Colorectal Dis. 2024. PMID: 38017593
-
Complete mesocolic excision with central venous ligation/D3 lymphadenectomy for colon cancer - A comprehensive review of the evidence.Surg Oncol. 2022 Jun;42:101755. doi: 10.1016/j.suronc.2022.101755. Epub 2022 Apr 2. Surg Oncol. 2022. PMID: 35405620 Review.
-
Complete Mesocolic Excision and Extent of Lymphadenectomy for the Treatment of Colon Cancer.Surg Oncol Clin N Am. 2022 Apr;31(2):293-306. doi: 10.1016/j.soc.2021.11.009. Epub 2022 Mar 5. Surg Oncol Clin N Am. 2022. PMID: 35351279 Review.
Cited by
-
Artificial intelligence for pre-operative lymph node staging in colorectal cancer: a systematic review and meta-analysis.BMC Cancer. 2021 Sep 26;21(1):1058. doi: 10.1186/s12885-021-08773-w. BMC Cancer. 2021. PMID: 34565338 Free PMC article.
-
Colon cancer: the 2023 Korean clinical practice guidelines for diagnosis and treatment.Ann Coloproctol. 2024 Apr;40(2):89-113. doi: 10.3393/ac.2024.00059.0008. Epub 2024 Apr 30. Ann Coloproctol. 2024. PMID: 38712437 Free PMC article.
-
Best Evidence for Each Surgical Step in Minimally Invasive Right Hemicolectomy: A Systematic Review.Ann Surg Open. 2023 Oct 5;4(4):e343. doi: 10.1097/AS9.0000000000000343. eCollection 2023 Dec. Ann Surg Open. 2023. PMID: 38144490 Free PMC article. Review.
-
Is radix ligation of the inferior mesenteric artery effective in Japanese-Style D3 radical lymph node dissection for sigmoid colon and rectal cancer surgery?-a single-center retrospective analysis since 2002.J Gastrointest Oncol. 2025 Apr 30;16(2):591-598. doi: 10.21037/jgo-24-815. Epub 2025 Mar 17. J Gastrointest Oncol. 2025. PMID: 40386605 Free PMC article.
-
Is computed tomography assessment of residual arterial pedicle length following colorectal cancer surgery a useful marker of surgical quality?Tech Coloproctol. 2025 Apr 12;29(1):101. doi: 10.1007/s10151-025-03130-6. Tech Coloproctol. 2025. PMID: 40220058 Free PMC article.
References
-
- Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer: complete mesocolic excision and central ligation-technical notes and outcome. Colorectal Dis 2009; 11: 354-64. discussion 64-5.
-
- West NP, Hohenberger W, Weber K, Perrakis A, Finan PJ, Quirke P. Complete mesocolic excision with central vascular ligation produces an oncologically superior specimen compared with standard surgery for carcinoma of the colon. J Clin Oncol 2010; 28: 272-8.
-
- Bertelsen CA, Neuenschwander AU, Jansen JE et al. Disease-free survival after complete mesocolic excision compared with conventional colon cancer surgery: a retrospective, population-based study. Lancet Oncol 2015; 16: 161-8.
-
- Sondenaa K, Quirke P, Hohenberger W et al. The rationale behind complete mesocolic excision (CME) and a central vascular ligation for colon cancer in open and laparoscopic surgery : proceedings of a consensus conference. Int J Colorectal Dis 2014; 29: 419-28.
-
- Yamamoto S, Inomata M, Katayama H et al. Short-term surgical outcomes from a randomized controlled trial to evaluate laparoscopic and open D3 dissection for stage II/III colon cancer: Japan Clinical Oncology Group Study JCOG 0404. Ann Surg 2014; 260: 23-30.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous